Gastroesophageal Reflux: all 1,086 studies

Page 11 of 11. Open to participants first (187), then studies with results posted, then the rest; newest registration first within each.

• Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERDCompletedNCT00410592Phase 4
• A Study To Investigate The Effectiveness Of AH234844 (Lavoltidine) Compared With NEXIUM And Ranitidine.CompletedNCT00405119Phase 2
• Prescription Methods Assessment Project (PMAP)TerminatedNCT00393653Not applicable
• Examine National Characteristics & Outcome Measures of GERD Patients Using the PPI Acid Suppression Symptom (PASS) Test for ResponseCompletedNCT00392002Phase 4
• PPI Sequencing StudyCompletedNCT00384592Phase 4
• Clinical Trial Comparing Open and Laparoscopic Nissen Fundoplication in ChildrenCompletedNCT00382850Not applicable
• Esophageal and Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal RefluxCompletedNCT00373997Phase 4
• Study Evaluating Pantoprazole in Adolescents With GERDCompletedNCT00367614Phase 3
• Evaluation of the Efficiency of Autologous Adipocytes Graft in Endoscopic Treatment in Vesico-Renal Reflux in ChildrenStatus unknownNCT00367159Phase 3
• Tongue Exercises and Reflux Therapy for Upper Airway Resistance SyndromeWithdrawnNCT00364481Phase 1
• CYP2C19 Genetic Polymorphism on the Accuracy of Proton-Pump Inhibitor TestingCompletedNCT00354757Phase 4
• Symptom Adapted Therapy in GERD PatientsCompletedNCT00343161Phase 4
• Symptom Assessment in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) or enGERD (Endoscopic-negative GERD) After Treatment With Pantoprazole (BY1023/M3-343)CompletedNCT00336219Phase 3
• Serial Exhaled Breath pH MonitoringStatus unknownNCT00330603
• Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Non-erosive Reflux or Gastroesophageal Reflux Disease (BY1023/DE-004)CompletedNCT00326027Phase 3
• Comparison of the Classical Healing Concept With the Complete Remission Concept After Treatment With Pantoprazole in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) (BY1023/M3-342)CompletedNCT00325676Phase 4
• The Use of Lansoprazole to Treat Infants With Symptoms of Gastroesophageal RefluxCompletedNCT00324974Phase 3
• to Assess the Efficacy and Safety of the Probiotic E. Coli Strain M17 on Patients With GERDCompletedNCT00324532Phase 3
• Study of an Oropharyngeal Aerosolized pH Probe for Diagnosing Laryngopharyngeal Reflux (LPR)CompletedNCT00321503
• Effect of Pantoprazole on the Symptoms of Acid Reflux Disease in Adult Patients (BY1023/M3-341)CompletedNCT00312806Phase 3
• Study of Pantoprazole for Sleepiness Associated With Acid Reflux and Sleep ApneaCompletedNCT00307944Phase 4
• Comparison of the Nighttime Effects of Two Different Drugs on Subjects With GERDCompletedNCT00304421Phase 4
• Randomized Trial for Pharmacogenomics-based Proton Pump Inhibitor Therapy in ChildrenWithdrawnNCT00299845Phase 4
• Nexium 40mg Once Daily vs Prevacid 30mg Twice a Day for Control of Severe GERDCompletedNCT00295685Phase 4
• Validation of RDQ QuestionnaireCompletedNCT00291746Phase 4
• Necessity of Esophageal Dissection During Laparoscopic FundoplicationCompletedNCT00287612Not applicable
• Sleep Disorders and Gastroesophageal Reflux Disease (GERD)CompletedNCT00287391Phase 4
• Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy VolunteersCompletedNCT00284908Phase 1
• Prevacid vs Lifestyle Modifications for the Treatment of LPRStatus unknownNCT00274339Not applicable
• Esomeprazole in PPI Failures - IMPROVECompletedNCT00272701Phase 4
• Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose and Half Dose in Adult Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/UK-506)CompletedNCT00261339Phase 4
• Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708)CompletedNCT00261300Phase 3
• Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux DiseaseActive, not recruitingNCT00260572
• Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese PopulationCompletedNCT00259077Phase 3
• ASTERIX: Low Dose ASA and NexiumCompletedNCT00251966Phase 3
• Chest Pain Pilot StudyCompletedNCT00251901Phase 3
• Role of Pain Modulation in GERD Patients Who Failed Standard Dose Proton Pump Inhibitors (PPI)CompletedNCT00251732Phase 4
• Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340)CompletedNCT00246909Phase 4
• HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related DiseaseCompletedNCT00243724Phase 3
• An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)CompletedNCT00242736Phase 4
• Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent PatientsCompletedNCT00241501Phase 3
• Quantifying Effects of Treatment of Pediatric DysphoniaTerminatedNCT00237679Not applicable
• A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) and a History of Nighttime HeartburnCompletedNCT00237367Phase 4
• A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy.Status unknownNCT00237068Phase 4
• A Study of Efficacy and Safety of "On-demand" Maintenance Therapy With Rabeprazole in Patients With Non-erosive Reflux Disease (NERD)CompletedNCT00236392Phase 3
• Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled StudyCompletedNCT00235677Phase 3
• Improvement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid SuppressionCompletedNCT00234117Not applicable
• Functional and Molecular Characterisation of Oesophageal Distal Epithelium: Correlations With Acid and Non Acid RefluxStatus unknownNCT00231881
• Laparoscopy in Children: Does it Decrease the Metabolic, Endocrine and Inflammatory Stress Response to SurgeryCompletedNCT00231543Not applicable
• Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine -CompletedNCT00229424Phase 3
• Esomeprazole for Treatment of GERD in Pediatric PatientsCompletedNCT00228527Phase 4
• Rectal and Oral Omeprazole Treatment of Reflux Disease in Infants.CompletedNCT00226044Phase 3
• Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD)CompletedNCT00222170Phase 2
• Evaluation of Esomeprazole in Treating Gastro-esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation TherapyTerminatedNCT00222079Not applicable
• A Study to Evaluate the Effect of Lansoprazole on Infants With Gastroesophageal Reflux Disease.CompletedNCT00220818Phase 1
• Evaluation of Efficiency of Esophageal Capsule Endoscopy in the Screening of Patients With Gastroesophageal Reflux Disease or Dyspepsia as Compared to Upper EndoscopyCompletedNCT00217347Not applicable
• A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD)CompletedNCT00216489Phase 4
• Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.CompletedNCT00214552Phase 3
• Proton Pump Inhibitor Therapy for Mild to Moderate Obstructive Sleep ApneaWithdrawnNCT00211614Not applicable
• NEXIUM® in the Treatment of Moderate and Severe Erosive EsophagitisCompletedNCT00206180Phase 4
• Laryngopharyngeal Reflux and Proton Pump Inhibitor (PPI) TreatmentCompletedNCT00204698Phase 2/3
• Importance of Non-Acid Reflux in Asthma in ChildrenCompletedNCT00200980
• Evaluation of the Efficiency of Radiofrequency in the Treatment of Gastroesophageal Reflux DiseaseCompletedNCT00200642Not applicable
• An Evaluation of the Medtronic Gatekeeper System in the Treatment of SUBJECTS With Gastroesophageal Reflux Disease (GERD)TerminatedNCT00200044Not applicable
• Study Comparing a Pantoprazole Formulation to the Currently Marketed Tablet for GERD and Erosive EsophagitisCompletedNCT00195208Phase 3
• Evaluation of Gastroesophageal Reflux in Patients on Continuous Positive Airway Pressure Ventilation for Obstructive Sleep ApneaCompletedNCT00194376Not applicable
• Determination of Voiding Patterns of Children With Vesicoureteral RefluxCompletedNCT00186199
• On Demand Treatment of Reflux DiseaseCompletedNCT00184522Phase 4
• A Randomized Controlled Trial of Laparoscopic Nissen Fundoplication Treatment of Patients With Chronic GERDCompletedNCT00182260Not applicable
• Natural History of Gastroesophageal Reflux (GER) in Children and AdolescentsCompletedNCT00181805
• A Study to Evaluate the Effect of Lansoprazole on Hospitalized Neonates With Gastroesophageal Reflux DiseaseCompletedNCT00174928Phase 1
• Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).CompletedNCT00171483Phase 3
• Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).CompletedNCT00171418Phase 3
• Which Supraesophageal Reflux Symptoms Reliably Respond to Proton-Pump-Inhibitor (PPI) TherapyCompletedNCT00170001Not applicable
• Development of a Novel Disease-Specific Quality of Life Questionnaire for Gastroesophageal Reflux Disease (GERD) Patients in Chinese PopulationCompletedNCT00165022
• Symptomatic Gastroesophageal Reflux Disease: Double Blind Randomized Controlled Study of On-demand Therapy Versus Maintenance TherapyCompletedNCT00164840Phase 3
• The Role of Visceral Hyperalgesia, Gastroesophageal Reflux Disease (GERD) and Esophageal Motility Disorder (EMD) in NCCP PatientsTerminatedNCT00164814
• The Prevalence and Significance of Gastro-oesophageal Reflux in Cystic Fibrosis Before and After Lung TransplantationStatus unknownNCT00164021
• Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-339)CompletedNCT00163306Phase 3
• Immunologic Factors in Reflux Esophagitis and Barrett's EsophagusStatus unknownNCT00155805
• 24 Hour Esophageal and Electrogastrography to Investigate the Mechanism of Reflux EsophagitisStatus unknownNCT00154570
• A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD)CompletedNCT00149851Phase 2
• Famotidine in Subjects With Non-erosive Gastroesophageal Reflux DiseaseCompletedNCT00141960Phase 2/3
• Medical and Surgical Treatment of Esophageal RefluxCompletedNCT00061724
• Economic Impact of Guidelines for Gastroesophageal Reflux DiseaseCompletedNCT00057174Not applicable
• Phase III Study of Chondrocyte Alginate Gel Suspension in Pediatric Patients With Vesicoureteral RefluxStatus unknownNCT00004487Phase 3

← Gastroesophageal Reflux overview